Agape ATP Corp

Agape ATP Corp (ATPC) Stock Analysis

$1.370

+0.131 (+9.59%)At close

Loading chart…
High
1.425
Open
1.290
VWAP
1.36
Volume
12.20K
Mkt Cap
—
Low
1.280
Amount
16.57K
EV/EBITDA, TTM
0.00

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.

AI analysis of Agape ATP Corp (ATPC)

Sell

Agape ATP Corp (ATPC) is not a good buy right now due to its significant price decline and poor financial performance. The current price is $1.25, which is 97.97% lower than its 1-year high of $73.50. The RSI is at 33.51, indicating that the stock is oversold but lacks momentum for recovery. Furthermore, the forward P/E ratio is 0, suggesting no earnings growth expectations, and the gross margin is only 85.96%, which, while high, is overshadowed by the company's overall financial instability. The main risk is the 76.19% year-to-date decline, indicating severe market sentiment against the stock.

Valuation Metrics

The current forward P/E ratio for Agape ATP Corp (ATPC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for ATPC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ATPC

$1.53

Scenario price

B

Base

Base · 50%ATPC

$1.40

Scenario price

B

Bear

Bear · 25%ATPC

$1.25

Scenario price

Events Timeline

2026-03-12 (ET)

09:20:00

Agape ATP Regains Nasdaq Listing Compliance

2026-03-10 (ET)

09:30:00

AGAPE ATP Enters Collaboration Agreement with Citadel Investment

2026-02-09 (ET)

20:00:00

Agape ATP Corp Trading Halted, News Pending

2026-02-06 (ET)

13:40:00

Agape ATP Files $200M Mixed Securities Shelf

2026-02-05 (ET)

09:10:00

Agape ATP Corporation Faces Potential Nasdaq Delisting

News

ATPC FAQ — answered by Alphio AI

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual. It operates in the Healthcare sector.

Agape ATP Corp (ATPC) is not a good buy right now due to its significant price decline and poor financial performance. The current price is $1.25, which is 97.97% lower than its 1-year high of $73.50. The RSI is at 33.51, indicating that the stock is oversold but lacks momentum for recovery. Furthermore, the forward P/E ratio is 0, suggesting no earnings growth expectations, and the gross margin is only 85.96%, which, while high, is overshadowed by the company's overall financial instability. The main risk is the 76.19% year-to-date decline, indicating severe market sentiment against the stock.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading